Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$8.35 - $12.6 $24,440 - $36,880
-2,927 Closed
0 $0
Q1 2020

Apr 27, 2020

BUY
$10.23 - $24.56 $2,444 - $5,869
239 Added 8.89%
2,927 $34,000
Q3 2019

Oct 31, 2019

BUY
$16.36 - $21.39 $490 - $641
30 Added 1.13%
2,688 $50,000
Q4 2018

Jan 17, 2019

BUY
$22.03 - $32.01 $4,956 - $7,202
225 Added 9.25%
2,658 $69,000
Q2 2018

Jul 27, 2018

BUY
$26.4 - $42.0 $8,712 - $13,860
330 Added 15.69%
2,433 $95,000
Q1 2018

May 08, 2018

BUY
$18.43 - $28.8 $7,519 - $11,750
408 Added 24.07%
2,103 $58,000
Q2 2017

Aug 09, 2017

BUY
N/A
1,695
1,695 $23,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Ironwood Financial, LLC Portfolio

Follow Ironwood Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Financial, LLC with notifications on news.